Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB01278_nanopub.RA2YSzBAR_NafFAgdwobgSLtmZutfxr6ANZj2yP2ezgnY#assertion>. }
Showing items 1 to 19 of
19
with 100 items per page.
- drugbank:DB01278 type drugbank_vocabulary:Drug assertion.
- drugbank:DB01278 label "Pramlintide [drugbank:DB01278]" assertion.
- drugbank:DB01278 seeAlso symlin.htm assertion.
- drugbank:DB01278 seeAlso pramlintide.html assertion.
- drugbank:DB01278 seeAlso DB01278 assertion.
- drugbank:DB01278 description "Pramlintide is a relatively new adjunct treatment for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals. It is derived from amylin, a hormone that is released into the bloodstream, in a similar pattern as insulin, after a meal. Like insulin, amylin is deficient in individuals with diabetes." assertion.
- drugbank:DB01278 identifier "drugbank:DB01278" assertion.
- drugbank:DB01278 title "Pramlintide" assertion.
- drugbank:DB01278 drugbank_vocabulary:x-cas cas:151126-32-8 assertion.
- drugbank:DB01278 drugbank_vocabulary:drugbank-id "DB01278" assertion.
- drugbank:DB01278 bio2rdf_vocabulary:x-identifiers.org DB01278 assertion.
- drugbank:DB01278 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB01278" assertion.
- drugbank:DB01278 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB01278 bio2rdf_vocabulary:identifier "DB01278" assertion.
- drugbank:DB01278 drugbank_vocabulary:x-wikipedia wikipedia:Pramlintide assertion.
- drugbank:DB01278 drugbank_vocabulary:x-pharmgkb pharmgkb:PA164781394 assertion.
- drugbank:DB01278 drugbank_vocabulary:x-kegg kegg:D05595 assertion.
- drugbank:DB01278 drugbank_vocabulary:x-atc atc:A10BX05 assertion.
- drugbank:DB01278 drugbank_vocabulary:x-ndc ndc:66780-115-02 assertion.